Linda Marban

Linda Marban, Ph.D., is the President, CEO and Director of Capricor Therapeutics, Inc., a publicly traded biotechnology company, and Co-Founder of Capricor, Inc., a wholly owned subsidiary of Capricor Therapeutics. Dr. Marban has been with Capricor, Inc., since 2005 and became its Chief Executive Officer in 2010. She combines her background in research with her business experience to lead Capricor and create a path to commercialization for its novel stem-cell cardiac therapies. Dr. Marban was the lead negotiator in procuring the license agreements that are the foundation of Capricor, Inc.’s intellectual property portfolio. Under her direction as Chief Executive Officer, Capricor, Inc., secured approximately $27 million in nondilutive grants and a loan award, which funds Capricor, Inc.’s R&D programs and clinical trials involving its CAP-1002 product. From 2003 to 2009, Dr. Marban was with Excigen, Inc., a biotechnology startup company, where she was responsible for business development, operations, preclinical research and supervising the development of gene therapy products in a joint development agreement with Genzyme Corp. Dr. Marban began her career in academic science, first at the Cleveland Clinic Foundation working on the biophysical properties of cardiac muscle. That work continued when she moved to a postdoctoral fellowship at Johns Hopkins University. Dr. Marban earned a Ph.D. from Case Western Reserve University in cardiac physiology.